Evidence map›Paper›PMID 22717389›Full record

ArticleThe International journal on drug policy2012

Opiate use, treatment, and harm reduction in Afghanistan: recent changes and future directions.

Catherine S Todd, David Macdonald, Kaveh Khoshnood, G Farooq Mansoor, Mark Eggerman, Catherine Panter-Brick

Abstract read
In one paragraph

Article in The International journal on drug policy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. The ups and downs of harm reduction in Afghanistan.The Lancet regional health. Southeast Asia · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Catherine S ToddDepartment of Obstetrics & Gynaecology, Columbia University, 622 West 168th Street, PH 16-69, New York, NY 10032, USA. cst2121@columbia.edu
David Macdonald
Kaveh Khoshnood
G Farooq Mansoor
Mark Eggerman
Catherine Panter-Brick

Funding

Blood-borne infection screening in an Afghan antenatal populationK01TW007408 · FIC · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TODD, CATHERINE SUZANNE · 2005 to 2010
$538k
FIC NIH HHS K01 TW007408FIC NIH HHS K01TW007408
6 · The paper itself

Abstract

Afghanistan leads global opium and cannabis production, amidst concerted efforts to improve the country's infrastructure. In this commentary, the evidence base for drivers of increased drug use in the context of deteriorating security is presented, government, donor, and civil society responses to date are described, and key areas for health policy response are summarized. Opiate use in Afghanistan shows disturbing trends: multiple substances are accessible at low cost and frequently used in combination, and injecting use has become more common. Pressures from both donor and governmental sectors have compromised innovations in programming. Further, civil unrest and resultant displacement have created challenges for programme implementation. Afghanistan urgently needs a well-funded, sustainable, comprehensive, and inclusive programme of drug dependency treatment, aftercare, and harm reduction services, as well as realistic, effective, and culturally salient primary prevention programmes. To date, drug dependence is not a prioritised issue, current programmes are under-resourced, and the continuum of care has a narrow scope generally limited to treatment. Unless this issue is addressed, the next generation of Afghans is poised to become a casualty of the opiate industry.

Indexed as

Harm ReductionHealth PolicyAfghanistanAftercareAgricultureCannabisHumansOpioid-Related DisordersOpiumSubstance Abuse, IntravenousOpium

Identifiers

PMID22717389
PMCPMC7153691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.